ExploreWatchlistsPricing
  1. JP-listed companies
  2. SYSMEX CORPORATION
  3. Financials
  4. Repurchases of common stock

SYSMEX CORPORATION (6869)

Market cap
¥907.1B
P/E ratio
24.9x
Develops and manufactures medical testing equipment and reagents for blood tests and urinalysis, serving healthcare institutions worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRepurchases of common stock (Million JPY)YoY (%)
Mar 31, 2026-3,214+160600.00%
Mar 31, 2025-2-99.98%
Mar 31, 2024-12,001+1200000.00%
Mar 31, 2023-1-75.00%
Mar 31, 2016-4-60.00%
Mar 31, 2015-10

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat